FitLife Brands sees Q2 revenue growth (5%)-(4%) from 2Q24 revenue of $15.98M

Q2 revenue consensus $16.92M. The decline in revenue is attributed almost entirely to MRC. Expects to report wholesale and online revenue growth for Legacy FitLife and a slight decline in wholesale and online revenue for MusclePharm. Excluding MRC, consolidated revenue for the rest of the business is expected to be approximately 4% higher than the same period last year. Expects Q2 net income $1.6M-$1.8M including the effect of approximately $0.7M of transaction-related expense during the quarter. Expects Q2 adjusted EBITDA $3.2M-$3.4M. Regarding MRC, the primary reason for the year-over-year decline is the performance of a best-selling product under the Dr. Tobias brand.